Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Blocklisting Interim Review

1 Oct 2013 10:00

RNS Number : 3859P
Centaur Media PLC
01 October 2013
Ā 



BLOCK LISTING SIX MONTHLY RETURN

Ā 

Information provided on this form must be typed or printed electronically.

Ā 

To: The FCA

Ā 

Date 1 October 2013

Ā 

AVS No:

Ā 

Name of applicant:

Centaur Media Plc

Name of scheme:

Rollover Share Option Plan 2004

Period of return:

From:

1st April 2013

To:

30th September 2013

Balance under scheme from previous return:

302,935

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

N/a

Number of securities issued/allotted under scheme during period:

N/a

Balance under scheme not yet issued/allotted at end of period

302,935

Number and class of securities originally listed and the date of admission

2,108,887 - 1st April 2005

Total number of securities in issue at the end of the period

142,889,669

Ā 

Name of contact:

Claire Baty

Address of contact:

79 Wells Street, London, W1T 3QN

Telephone number of contact:

0207 970 4506

Ā 

SIGNED BY ______________________________________________

Claire Baty (Company secretary)

for and on behalf of

Centaur Media Plc

Ā 

Ā 

If you knowingly or recklessly give false or misleading information you may be liable to prosecution.

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
BLRLIFSTISLLIIV
Date   Source Headline
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading Update
21st Dec 20214:31 pmRNSDirector/PDMR Shareholding
22nd Nov 202111:24 amRNSDirector/PDMR Shareholding
12th Nov 20219:54 amRNSHolding(s) in Company
12th Nov 20219:52 amRNSHolding(s) in Company
10th Nov 202110:11 amRNSNotification of major holdings
1st Nov 20214:18 pmRNSHolding(s) in Company
1st Nov 20211:46 pmRNSHolding(s) in Company
1st Nov 202110:37 amRNSHolding(s) in Company
1st Nov 202110:33 amRNSHolding(s) in Company
20th Oct 202111:54 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSTrading Update
6th Oct 20219:30 amRNSHolding(s) in Company
21st Sep 202110:31 amRNSDirector/PDMR Shareholding
7th Sep 202112:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.